REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
67,90 BRL
0,00%
(0,00) 1 d.
15. 10., 16:54:30 GMT-3 · BRL
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre REGN34…
Trh. kap.
81,97 mld.
Priem. obj.
766,00
Objem
0,00
Max. za 52 týž.
73,13 BRL
Min. za 52 týž.
49,91 BRL
Akcie v obehu
101,14 mil.
Počet zamestnancov
15 tis.
Trh. kap.
81,97 mld.
Priem. obj.
766,00
Objem
0,00
Max. za 52 týž.
73,13 BRL
Min. za 52 týž.
49,91 BRL
Akcie v obehu
101,14 mil.
Počet zamestnancov
15 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 6 minútami
UBS lifts Regeneron stock target to USD 978.00
Traders Union
·
pred 2 hodinami
Regeneron Pharmaceuticals receives EMA committee approval for alternative immunotherapy dosing after stock ends session up 2.2%
Stock Titan
·
pred 2 hodinami
EU advisers recommend a 15-minute option for some cancer infusions after a tolerated first dose
Kalkine Media
·
pred 16 hodinami
Regeneron's Andrew Murphy Executes Stock Option and Sells Shares Under 10b5-1 Plan on October 14
Profil
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Informácie o subjekte Regeneron Pharmaceuticals Inc BDR
Generálny riaditeľLeonard Schleifer
Zamestnanci15,3 tis.
Dátum založenia1988
Hlavné sídloTarrytown, New York, Spojené štáty americké
Odvetvie-